Sign In
  • Africa
  • Trump
  • African
  • Guardian
  • Mail
  • South
logo
  • Home
  • Ghana
  • Africa
  • World
  • Politics
  • Business
  • Technology
  • Sports
  • Entertainment
  • Health
  • Crime
  • Lifestyle
Reading: ASH 2024: Roundup of news from last day of hematology meeting
Share
African News HeraldAfrican News Herald
Font ResizerAa
Search
  • Home
  • Ghana
  • Africa
  • World
  • Politics
  • Business
  • Technology
  • Sports
  • Entertainment
  • Health
  • Crime
  • Lifestyle
Follow US
© 2024 africanewsherald.com – All Rights Reserved.
African News Herald > Blog > Health > ASH 2024: Roundup of news from last day of hematology meeting
Health

ASH 2024: Roundup of news from last day of hematology meeting

ANH Team
Last updated: December 10, 2024 10:34 pm
ANH Team
Share
SHARE

“Epkinly might be the last best hope for many patients with chronic lymphocytic leukemia.”

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. It is characterized by the overproduction of abnormal white blood cells, which can crowd out healthy cells and interfere with normal blood cell production. While there have been significant advancements in the treatment of CLL in recent years, including targeted therapies and CAR-T cell therapy, patients with relapsed or refractory disease still face a grim prognosis.

One potential ray of hope for these patients is Abbvie’s Epkinly, also known as epcoritimab. Epkinly is a bispecific T-cell engager that works by engaging the body’s immune system to target and destroy cancer cells. In a small phase 1/2 trial presented at the recent American Society of Hematology meeting, researchers showed that Epkinly had promising results in patients with relapsed or refractory CLL.

Dr. Alexey Danilov, a hematologist-oncologist and cancer researcher at City of Hope, highlighted the success of Epkinly in this difficult-to-treat patient population. In the study, 61% of the 23 patients responded to the drug, and 39% achieved a complete response. This is particularly significant considering that many of these patients had high-risk mutations and had already failed other therapies, such as BTK inhibitors and CAR-T therapy.

One of the patients who participated in the trial was Brian Koffman, a retired family physician and founder of the CLL Society. Koffman had previously received multiple lines of therapy and had experienced relapse each time. However, with Epkinly, he achieved a complete response. While Koffman remains cautiously optimistic about the future, he acknowledges the challenges of living with a chronic cancer like CLL.

See also  Food and housing insecurity linked to unsafe gun storage

Dr. Danilov and his team believe that Epkinly could offer a much-needed lifeline to patients with relapsed or refractory CLL. The drug’s mechanism of action and promising response rates in a challenging patient population suggest that it could become an important part of the treatment landscape for CLL in the future.

As researchers continue to explore new treatment options and combinations for CLL, Epkinly stands out as a beacon of hope for patients who have exhausted other therapeutic options. While more research is needed to fully understand the long-term benefits and potential side effects of Epkinly, the initial results are encouraging and offer a glimmer of optimism for those living with this challenging disease. As we navigate through the ups and downs of life, it’s not uncommon to feel a sense of frustration or disappointment. We may encounter obstacles or challenges that seem insurmountable, leaving us with a desire to release our pent-up emotions. However, amidst the chaos and turmoil, there is always a glimmer of hope – a small light at the end of the tunnel that keeps us going.

In the words of the poet Rumi, “But you hope, by the end, there’s another can to kick.” This powerful statement reminds us that even when we feel like we’ve hit rock bottom, there is always the possibility of a new beginning. It’s a metaphorical representation of resilience and perseverance in the face of adversity.

Life is full of twists and turns, and just when we think we’ve reached a dead end, a new path may reveal itself. This notion of “another can to kick” symbolizes the endless opportunities for growth and transformation that exist in our lives. It encourages us to keep pushing forward, even when the odds are stacked against us.

See also  The Sandman Season 2: News, Cast, Trailer, And Release Date

When we face challenges or setbacks, it’s easy to feel defeated and discouraged. But it’s important to remember that every setback is an opportunity for growth and self-discovery. By embracing the idea of “another can to kick,” we can approach life with a sense of optimism and resilience.

In the grand scheme of things, life is a journey filled with both triumphs and tribulations. It’s how we choose to respond to these challenges that ultimately defines our character and shapes our future. So, the next time you find yourself facing a seemingly insurmountable obstacle, remember the words of Rumi and hold onto hope. Because in the end, there is always another can to kick.

Subscribe to Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

I have read and agree to the terms & conditions
TAGGED:ASHdayhematologymeetingNewsRoundup
Share This Article
Twitter Email Copy Link Print
Previous Article Suspects linked to Sinaloa Cartel accused of stealing cars near DIA Suspects linked to Sinaloa Cartel accused of stealing cars near DIA
Next Article Guardiola Announces Man City as Final Club Managerial Job
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Editor's Pick

Best Phone 2024: Top 10 Mobile Phones Today

Need a new phone? The constant influx of new handsets can make it challenging to keep track of what's worth…

November 12, 2024 3 Min Read
14 best trading platforms in Nigeria 

Avatrade is regulated by the Central Bank of Ireland, ASIC in Australia,…

20 Min Read
The fall of Ghana’s NPP and the resurgence of the NDC in the 2024

The 2024 general elections in Ghana marked a seismic shift in the…

8 Min Read

Lifestyle

‘South Africa needs brave men like Mkhwanazi,’ says Moja Love TV boss’ foundation

The Aubrey Tau Foundation has come out in support of…

July 9, 2025

7 reasons Gen Zs choose friends with benefits

With the fast-paced lives of Gen…

July 8, 2025

Discover the Netflix characters setting 2025 fashion trends

Netflix character fashion has become a…

July 8, 2025

Ayanda Thabethe says ‘I do’ in intimate wedding ceremony

TV presenter Ayanda Thabethe recently shared…

July 7, 2025

Upgrade PCs to upgrade security

The Rise of Cybercrime in Africa:…

July 7, 2025

You Might Also Like

Health

Exploring safer energy drink recipes to protect dental enamel

Energy drinks have become a popular choice for many individuals looking for a quick boost of energy. However, these beverages…

3 Min Read
Health

Trump tax bill exposes the lost clout of the health care lobby

The recent approval of President Trump's tax cut bill by Republicans has sparked concerns within the health care industry, as…

2 Min Read
Health

Reducing multiple tap water contaminants could prevent over 50,000 cancer cases

Water is an essential element for life, but the quality of our tap water can significantly impact our health. A…

3 Min Read
Health

STAT+: Fed-up and demoralized, FDA staff are leaving.

The recent July 4th celebrations at the Chesapeake Baysox game against the Richmond Flying Squirrels were filled with exciting events.…

2 Min Read
logo logo
Facebook Twitter Youtube

About US

Stay informed with the latest news from Africa and around the world. Covering global politics, sports, and technology, our site delivers in-depth analysis, breaking news, and exclusive insights to keep you connected with the stories that matter most.

Top Categories
  • Africa
  • Business
  • Entertainment
  • Sports
Usefull Links
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2024 africanewsherald.com –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?